Dick Simon

CEO and Co-Founder

Dick is the co-founder and CEO of Sensorium Therapeutics. A serial entrepreneur and leader in advancing psychedelic-assisted therapies, he is the Chairman of the Advisory Council of Center for the Neuroscience of Psychedelics at Massachusetts General Hospital, co-founder and board member of the Boston Psychedelic Research Group, and is on the steering committee for the Psychedelic Science Funders Collaborative. After September 11, 2001, Dick co-founded and led the YPO Peace Action Network which leverages personal and business relationships, resources, and expertise for conflict resolution on local and global levels. Dick’s work has earned him YPO’s Global Humanitarian Award, Harvard Business School’s Making a Difference Award, inclusion in Real Leaders magazine’s “100 Visionary Leaders” and in the “100 Most Influential People in Psychedelics” list. Dick holds a Master’s in Business Administration from Harvard Business School.

Scientific Co-Founders


Senior Director, Head of Computational Biology
Research Associate II, Neurobiology
Senior Research Associate, Neuroscience
Chief of Staff and Co-Founder
Senior Research Associate, Neurobiology
CEO and Co-Founder
Director, Neurobiology
Associate Director, Finance
Chief Scientific Officer
Senior Scientist, Computational Biology
Senior Manager, Finance
Scientist I, Computational Biology
Director, Drug Discovery
Vice President, Finance